The beneficial effects of intravenous immunoglobulin for antineutrophil cytoplasmic antibody-positive vasculitis

Israel Medical Association Journal

Volumn 14, Issue 9, 2012, Pages 568-569

  Svetlicky, Nina ^a,c   Blank, Miri ^a,c   Zandman Goddard, Gisele ^b,c  

^a SHEBA MEDICAL CENTER   (Israel)

^b WOLFSON MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Anti myeloperoxidase antibodies; Antineutrophil cytoplasmic antibody (ANCA) associated vasculitis; Churg strauss syndrome; Intravenous immunoglobulins (IVIG)

Indexed keywords

AUTOANTIBODY; CYCLOPHOSPHAMIDE; HYDROCORTISONE; IMMUNOGLOBULIN; LOW MOLECULAR WEIGHT HEPARIN; STEROID;

ANCA ASSOCIATED VASCULITIS; BLOOD PRESSURE; CHURG STRAUSS SYNDROME; CLINICAL TRIAL (TOPIC); COMORBIDITY; DISEASE ASSOCIATION; DRUG MEGADOSE; EDITORIAL; FLU LIKE SYNDROME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; NONHUMAN; REMISSION; SIDE EFFECT; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOEMBOLISM; TREATMENT OUTCOME; FEMALE; NOTE;

CHURG-STRAUSS SYNDROME; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS;

EID: 84871865038     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (18)

1. Baldini C, Talarico R, Della Rossa A, Bombardieri S. Clinical manifestations and treatment of Churg- Strauss syndrome. Rheum Dis Clin North Am 2010; 36 (3): 527-43.
2. Katz U, Shoenfeld Y, Zandman-Goddard G. Update on intravenous immunoglobulins (IVIg) mechanisms of action and off-label use in autoimmune diseases. Curr Pharm Des 2011; 17 (29): 3166-75.
3. Ballanti E, Di Muzio G, Novelli L, Perricone C, Perricone R. Churg-Strauss syndrome with neurologic manifestations: report of a case successfully treated with intravenous immunoglobulins. IMAJ Isr Med Assoc J 2012; 14: 583-5.
4. Kivity S, Katz U, Daniel N, Nussinovitch U, Papageorgiou N, Shoenfeld Y. Evidence for the use of intravenous immunoglobulins - a review of the literature. Clin Rev Allergy Immunol 2010; 38 (2-3): 201-69.
5. Sherer Y, Kuechler S, Jose Scali J, et al. Low dose intravenous immunoglobulin in systemic lupus erythematosus: analysis of 62 cases. IMAJ Isr Med Assoc J 2008; 10 (1): 55-7.
6. Zandman-Goddard G, Blank M, Shoenfeld Y. Intravenous immunoglobulins in systemic lupus erythematosus: from the bench to the bedside. Lupus 2009; 18 (10): 884-8.
7. Shoenfeld Y, Rauova L, Gilburd B, et al. Efficacy of IVIG affinity-purified anti-double-stranded DNA anti-idiotypic antibodies in the treatment of an experimental murine model of systemic lupus erythematosus. Int Immunol 2002; 14 (11): 1303-11.
8. Blank M, Anafi L, Zandman-Goddard G, et al. The efficacy of specific IVIG anti-idiotypic antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model. Int Immunol 2007; 19 (7): 857-65.
9. Mimouni D, Blank M, Payne AS, et al. Efficacy of intravenous immunoglobulin (IVIG) affinitypurified anti-desmoglein anti-idiotypic antibodies in the treatment of an experimental model of pemphigus vulgaris. Clin Exp Immunol 2010; 162 (3): 543-9.
10. Fuchs S, Feferman T, Meidler R, et al. A disease- specific fraction isolated from IVIG is essential for the immunosuppressive effect of IVIG in experimental autoimmune myasthenia gravis. J Neuroimmunol 2008; 194 (1-2): 89-96.
11. Svetlicky N, Ortega-Hernandez OD, Mouthon L, et al. The advantage of specific intravenous immu- noglobulin (IVIG) on regular IVIG - experience of the last decade. Clin Immunol 2012; in press.
12. Orbach H, Katz U, Sherer Y, Shoenfeld Y. Intravenous immunoglobulin: adverse effects and safe adm- inistration. Clin Rev Allergy Immunol 2005; 29 (3): 173-84.
13. Zandman-Goddard G, Krauthammer A, Levy Y, Langevitz P, Shoenfeld Y. Long-term therapy with intravenous immunoglobulin is beneficial in patients with autoimmune diseases. Clin Rev Allergy Immunol 2012; 42 (2): 247-55.
14. Zandman-Goddard G, Krauthammer A, Shoenfeld Y. The steroid-sparing effect of intravenous immunoglobulin in patients with autoimmune diseases. Expert Rev Clin Immunol 2007; 3 (5): 773-80.
15. Gorshtein A, Levy Y. Intravenous immunoglobulin in therapy of peripheral neuropathy. Clin Rev Allergy Immunol 2005; 29 (3): 271-9.
16. Levy Y, Uziel Y, Zandman GG, et al. Intravenous immunoglobulins in peripheral neuropathy associated with vasculitis. Ann Rheum Dis 2003; 62 (12): 1221-3.
17. Nakamura M, Yabe I, Yaguchi H, et al. Clinical characterization and successful treatment of 6 patients with Churg-Strauss syndrome-associated neuropathy. Clin Neurol Neurosurg 2009; 111 (8): 683-7.
18. Martinez V, Cohen P, Pagnoux C, et al. Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic auto- antibodies: results of a multicenter, prospective, open-label study of twenty-two patients. Arthritis Rheum 2008; 58 (1): 308-17.